Itaconix plc

Itaconix plc, alongside its affiliated entities, specializes in the creation, production, and distribution of bio-based polymers. These innovative materials serve the personal care, household product, and industrial sectors throughout North America and Europe. For home and industrial applications, its offerings encompass water-soluble polymers like Itaconix TSI, Itaconix DSP, Itaconix CHT, and Itaconix VELASOFT, as well as water-soluble odor neutralizers such as Itaconix ZINADOR 22L and 35L. In the personal care market, Itaconix supplies water-soluble fixating complexes, specifically Itaconix VELAFRESH ZP20 and ZP30, along with Nouryon Amaze SP, an ingredient for hair styling. Established in 2012, the company operated as Revolymer plc before adopting its current name, Itaconix plc, in February 2017. The firm's main office is located in Stratham, New Hampshire.

Itaconix plc trades as ITX.L on LSE. The company is classified in Basic Materials / Chemicals - Specialty and reports in GBP.

The current profile places the business in Chemicals - Specialty. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £10.72M of revenue and -£1.41M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Itaconix plc can be compared against peers such as Artemis Resources Limited, Cloudbreak Discovery Plc, Directa Plus Plc, Eden Research plc, Future Metals NL, Goldplat PLC.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £15.31M, beta of 1.01, and return on equity of -17.1%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

ITX.L currently shows total debt of £2.02M and beta of 1.01. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.itaconix.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.